Union Square Park Capital Management’s Acer Therapeutics Inc ACER Stock Holding History

Union Square Park Capital Management’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-26,633	Closed	-$21.7K	–	49
2023 Q3	$21.7K	Buy	+26,633	New	+$21.9K	0.03%	29

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Union Square Park Capital Management's ACER Position: Q4 2023 in Review

Union Square Park Capital Management sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 26,633 shares — an estimated $21.7K sold.

Union Square Park Capital Management first reported a position in ACER in Q3 2023 and held it in 1 quarter. The position peaked at $21.7K in Q3 2023. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Union Square Park Capital Management reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Union Square Park Capital Management sold 26,633 Acer Therapeutics Inc shares in Q4 2023, an estimated $21.7K.
Union Square Park Capital Management first reported a position in Acer Therapeutics Inc in Q3 2023 and held it in 1 quarter.
Union Square Park Capital Management's Acer Therapeutics Inc position peaked at $21.7K in Q3 2023.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Union Square Park Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.